When did TNXP split its shares?
Jul 26, 2021 · What happened Shares of Tonix Pharmaceuticals ( TNXP -5.26% ) were crashing 28.3% lower as of 10:24 a.m. EDT on Monday. The big decline came after Tonix announced on Friday following the market...
Is Tonix Pharmaceuticals (TNXP) a meme stock?
Sep 30, 2014 · Sep 29, 2014 3:27 PM EDT NEW YORK ( TheStreet) -- Shares of Tonix Pharmaceuticals ( TNXP) - Get Tonix Pharmaceuticals Holding Corp. Report plummeted 49.43% to $7.06 on Monday after the company...
Why did Tonix Pharmaceuticals shares crash 28% lower on Monday?
The Reason Why TNXP Dropped General Discussion Hey everyone. We figured out the reason behind the strange sudden drop at 10%, it was because a person here gave a large group of powerful daytraders this information, and they came in at .70c resistance to short it hard and go on a stop loss raid to tank the price and scare people away.
Is Tonix’s tnx-1900 FDA-approved?
Jul 27, 2018 · Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion. After its twelve-week trial, Tonmya, a drug that treats military-related post-traumatic stress disorder (PTSD), showed “inadequate separation from placebo.”.
Is TNXP a good stock to buy?
Is TONIX PHARMACEUTICALS HOLDING Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: TNXP) stock is to Hold TNXP stock.
Why did TNXP drop in 2016?
After scoring two promising FDA designations on its lead drug, tiny Tonix Pharmaceuticals is aborting its late-stage study in PTSD due to lousy results — nearly flat-lining the company's stock Friday morning.
Why was TNXP stock so high?
What happened. A big regulatory win was reaping huge prizes for Tonix Pharmaceuticals ( TNXP 3.26% ) on Thursday. Following a new nod from the Food and Drug Administration (FDA) for one of its leading pipeline drugs, the biotech's shares went on a quick trip skyward, rising 33% in price on the day.Mar 3, 2022
Is TNXP going to reverse split?
(Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on November 1, 2019.Oct 31, 2019
What TNX-102?
TNX-102 SL is a patented sublingual tablet formulation of cyclobenzaprine hydrochloride which provides rapid transmucosal absorption and reduced production of a long half-life active metabolite, norcyclobenzaprine, due to bypass of first-pass hepatic metabolism.Jul 23, 2021
Where is tonix Pharmaceuticals located?
Chatham, New jerseyTonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
Who is buying TNXP?
Volume fell on the last day by -8 million shares and in total, 20 million shares were bought and sold for approximately $3.79 million....Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Thursday, April 14, 2022.Fair opening price April 14, 2022Current price$0.19$0.19 (Overvalued)
Why did TNXP go up today?
Why Tonix Pharmaceuticals Rocketed 33% Higher Today Following a new nod from the Food and Drug Administration (FDA) for one of its leading pipeline drugs, the biotech's shares went on a quick trip skyward, rising 33% in price on the day.
Why is OCGN stock down?
Ocugen's OCGN stock declined 3.8% on Tuesday after the FDA placed a clinical hold on a phase II/III immuno-bridging and broadening clinical study on its COVID-19 vaccine, Covaxin.3 days ago
Where is Tonix Pharmaceuticals located?
Is Tonix halting Phase 3?
Tonix Pharmaceuticals is based in New York and specializes in producing drugs that treat specific central nervous system conditions. “These results underscore the challenges in designing and conducting well-controlled clinical studies in PTSD, especially military-related PTSD.
Is Tonix a Phase 2 drug?
Tonix Pharmaceuticals Holding Corp. ( NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion.
Signals & Forecast
In addition to its Tonmya drug, Tonix is currently working on a bedtime treatment drug for agitation in Alz heimer’s disease, which is currently in its Phase 2 of its trial.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Tonix Pharmaceuticals Holding Corp.
Is Tonix Pharmaceuticals Holding Corp. stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are very positive buying more shares than they are selling in Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
About Tonix Pharmaceuticals Holding Corp
In the last 100 trades there were 20.56 million shares bought and 10 thousand shares sold. The last trade was done 8 days ago by Lederman Seth who bough 5 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
Tonix Pharmaceuticals Holding Corp. engages in developing medicines for common disorders of the central nervous system. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
What is TNX 102?
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Who is the Motley Fool contributor for 2021?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for Long COVID Syndrome (Long COVID), which is now known officially as Post-Acute Sequelae of COVID-19 (PASC1). Tonix plans to meet the FDA in Q3 of 2021 to seek agreement on designing a potential Phase 2 study and the overall clinical development plan. TNX-102 SL is in the second Phase 3 trial (RALLY) for fibromyalgia. The interim analysis results are expected in Q3 of 2021, an
1 TNXP Stock's Price Graph & Average Annual Return
In this Motley Fool Live video recorded on April 28, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the best healthcare stocks that Robinhood investors like. Keith Speights: Robinhood stocks have just attracted a lot of attention in recent weeks and months.
2 How Tonix Pharmaceuticals Holding Corp (TNXP) Stock Performed Against The Entire Stock Market
Below is a graph showing closing prices of Tonix Pharmaceuticals Holding Corp (TNXP) for the past 10 years. The below chart uses adjusted close instead of market close prices. (Adjusted close factors in corporate or institutional level actions outside the market.)
4 10 Biggest One-Day Losses
You should not evaluate a stock in isolation. Rather, you will benefit more if you assess the performance against broad indices and similar stocks.
Conclusion
Let us now see 10 biggest one-day losses of Tonix Pharmaceuticals Holding Corp (TNXP) stock.
Want to become a smart investor?
Hopefully, the above report helps you learn about the past ten-year performance of Tonix Pharmaceuticals Holding Corp (TNXP) shares. Kindly use the sections below to suggest corrections or improvements to the report.
What is TNX 102 SL?
Netcials reports section helps you with deep insights into the performance of various assets over the years. We are constantly upgrading and updating our reports section. Feel free to access them. Do not forget to leave your feedback.
Is Tonix aborting its study?
Tonmya, also known as TNX-102 SL, had received breakthrough therapy designation from the FDA for its applications in PTSD. And just this month, the agency also handed over fast track status for the drug in a different indication: agitation in Alzheimer’s.
When did TNXP split?
Brittany Meiling. After scoring two promising FDA designations on its lead drug, tiny Tonix Pharmaceuticals is aborting its late-stage study in PTSD due to lousy results — nearly flat-lining the company’s stock Friday morning. The drug, called Tonmya, apparently failed to improve PTSD symptoms when compared to placebo, ...
When did the first TNXP split take place?
For example, a 100 share position pre-split, became a 10 share position following the split. TNXP's third split took place on November 01, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of TNXP owned pre-split, the shareholder now owned 1 share.
Why are $5 and $10 pricepoints important?
The first split for TNXP took place on March 17, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of TNXP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. TNXP's second split took place on November 28, 2018.
What happens when a company reverses its split?
This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility.
When will Tonix start testing for PTSD?
So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Is Tonix a late stage company?
Tonix previously noted that it may begin a late-stage study for PTSD in the first quarter of 2017. This remains a large risk, but there have effectively not been new treatments for PTSD for a decade and a half.